References
- 1. Kim, DH: Gut microbiota-mediated drug-antibiotic interactions Drug Metabolism and Disposition 2015, 43: 1581-1589.10.1124/dmd.115.063867
- 2. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57: 1470-1481.10.2337/db07-1403
- 3. Bertkova I, Hijova E, Chmelarova A, Mojzisova G, Petrasova D, Strojny L, Bomba A, Zitnan R: The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma 2010, 57: 422-428.10.4149/neo_2010_05_422
- 4. Dabek M, McCrae SI, Stevens VJ, Duncan SH, Louis P: Distribution of β-glucosidase and β-glucuronidase activity and of β-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol 2008,66: 487-495.10.1111/j.1574-6941.2008.00520.x
- 5. Rowland IR, Rumney CJ, Coutts JT, Lievense LC: Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998, 19: 281-285.10.1093/carcin/19.2.281
- 6. Strojný L, Bomba A, Hijová E, Chmelárová A, Mojžišová G, Bertková I, Koprovičová J, Pomfy M, Strompfová V, Molokáčová M: Effects of probiotic in combination with prebiotics on intestinal lac tobacilli and coliforms and activities of bacterial enzymes in 1,2-dimethylhydrazine exposed rats. Czech J Anim Sci 2011,56: 99–106.10.17221/56/2010-CJAS
- 7. Juskiewicz J, Zdunczyk Z, Wroblewska M, Oszmianski J, Hernandez T: The responce of rats to feeding with diets containing grapefruit flavonoid extract. Food Res Int 2002,35: 201-205.10.1016/S0963-9969(01)00184-3
- 8. Plotnikoff GA: Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment. Global Adv Health Med 2014,3: 33-43.10.7453/gahmj.2014.021403061224891992
- 9. McBain AJ, Macfarlane GT: Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol 1998,47: 407-416.10.1099/00222615-47-5-4079879941
- 10. Blaut M, Clavel T: Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 2007,137: 751S-755S.10.1093/jn/137.3.751S17311972
- 11. DePreter V, Raemen H, Cloetens L, Houben E, Rutgeerts P, Verbeke K: Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr 2008, 62: 225-231.10.1038/sj.ejcn.160270617327863
- 12. Hijová E, Šoltésová A, Salaj R, Kuzma J, Strojný L, Bomba A: Use of the prebiotic inulin in the prevention of adverse signs of acute colitis. Acta Veterinaria-Beograd 2015,65: 339-347.10.1515/acve-2015-0028
- 13. Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, Benno Y: Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol 2002,45: 487-490.10.1111/j.1348-0421.2002.tb02723.x12222935
- 14. Changhoon P, Jiwoon J, Kyuhyung Ch, Jae Chul L, Oh Sung K, Sung-Hoon K, Chanhee Ch: Inhibition of in vitro growth of porcine Enterotoxigenic and Shiga toxin-producing Escherichia coli by Lactobacillus plantarum. Acta Veterinaria-Beograd 2015, 65, 429-435.10.1515/acve-2015-0035
- 15. Gill CIR, Rowland IR: Diet and cancer: assessing the risk. Br J Nutr 2002, 88: S73-S87.10.1079/BJN200263212215186
- 16. Panwar H, Calderwood D, Grant IR, Grover S, Green BD: Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against alpha- and beta-glucosidases suggesting anti-diabetic potential. Eur J Nutr 2014, 53: 1465-1474.10.1007/s00394-013-0649-924414142
- 17. Michlmayr H, Kneifel W: β-Glucosidase activities of lactic acid bacteria: mechanisms, impact on fermented food and human health. FEMS Microbial Lett 2014, 352: 1-10.10.1111/1574-6968.1234824330034
- 18. Mroczynska M, Libudzisz Z: β-Glucuronidase and β-Glucosidase activity of lactobacillus and Enterococcus isolated from human feces. Pol J Microbiol 2010, 59: 265-269.10.33073/pjm-2010-040
- 19. Sobhani J, Nhieu JT: Colon cancer is associated with microbial dysbiosis in humans and animals. Govaresh 2013,18: 45-56.
- 20. Arthur JC, Jobin C: The struggle within: microbial influences in colorectal cancer. Inflamm Bowel Dis 2011,17: 396-409.10.1002/ibd.21354337640520848537
- 21. An HM, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, Lim HT, Kim KJ, Ha NJ: Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids in Health and Disease 2011, 10: 1-8.10.1186/1476-511X-10-116314684921745411